These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33524560)

  • 1. An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway.
    Ren X; Wang N; Zhou Y; Song A; Jin G; Li Z; Luan Y
    Acta Biomater; 2021 Apr; 124():179-190. PubMed ID: 33524560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy.
    Chen X; Jiang Z; Lin Y; Yu C; Nie X; Xu G; Xu W; Jiang Y; Luan Y
    J Control Release; 2023 Jun; 358():345-357. PubMed ID: 37150404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
    Qu J; Zhao X; Ma PX; Guo B
    Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An injectable thermosensitive photothermal-network hydrogel for near-infrared-triggered drug delivery and synergistic photothermal-chemotherapy.
    Liu C; Guo X; Ruan C; Hu H; Jiang BP; Liang H; Shen XC
    Acta Biomater; 2019 Sep; 96():281-294. PubMed ID: 31319202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel-mediated tumor T cell infiltration and immune evasion to reinforce cancer immunotherapy.
    Xu G; Liu K; Chen X; Lin Y; Yu C; Nie X; He W; Karin N; Luan Y
    Nanoscale Horiz; 2024 Jan; 9(2):295-304. PubMed ID: 38086653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable thermosensitive hydrogel to enhance the photothermal ablation and systemic immunotherapy of breast tumors.
    Qin T; Li R; Jin H; Wang Y; Feng L
    Biomater Sci; 2022 Oct; 10(20):6003-6012. PubMed ID: 36053224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation.
    Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G
    ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable self-healing cellulose hydrogel based on host-guest interactions and acylhydrazone bonds for sustained cancer therapy.
    Jiang X; Zeng F; Yang X; Jian C; Zhang L; Yu A; Lu A
    Acta Biomater; 2022 Mar; 141():102-113. PubMed ID: 34990813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect.
    Cheng F; Su T; Zhou S; Liu X; Yang S; Lin S; Guo W; Zhu G
    Sci Adv; 2023 Jul; 9(28):eade6257. PubMed ID: 37450588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment.
    Cheng Z; Xue C; Liu M; Cheng Z; Tian G; Li M; Xue R; Yao X; Zhang Y; Luo Z
    Acta Biomater; 2023 Oct; 169():289-305. PubMed ID: 37544392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy.
    Zhang D; Li Q; Chen X; Nie X; Xue F; Xu W; Luan Y
    Small; 2022 Aug; 18(32):e2202663. PubMed ID: 35843879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
    Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH
    Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment.
    Liu Y; Geng Y; Yue B; Lo PC; Huang J; Jin H
    Front Immunol; 2021; 12():832942. PubMed ID: 35111169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-shot prophylactic tumor vaccine enabled by an injectable biomembrane hydrogel.
    Nie X; Shi C; Chen X; Yu C; Jiang Z; Xu G; Lin Y; Tang M; Luan Y
    Acta Biomater; 2023 Oct; 169():306-316. PubMed ID: 37574158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable biodegradation-visual self-healing citrate hydrogel with high tissue penetration for microenvironment-responsive degradation and local tumor therapy.
    Wang M; Chen M; Niu W; Winston DD; Cheng W; Lei B
    Biomaterials; 2020 Dec; 261():120301. PubMed ID: 32871470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis-Targeting Chimeras Enhanced Immunotherapy.
    Wu Y; Chang X; Yang G; Chen L; Wu Q; Gao J; Tian R; Mu W; Gooding JJ; Chen X; Sun S
    Adv Mater; 2023 Mar; 35(12):e2210787. PubMed ID: 36656993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.
    Jin H; Wan C; Zou Z; Zhao G; Zhang L; Geng Y; Chen T; Huang A; Jiang F; Feng JP; Lovell JF; Chen J; Wu G; Yang K
    ACS Nano; 2018 Apr; 12(4):3295-3310. PubMed ID: 29558107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment.
    Gu J; Zhao G; Yu J; Xu P; Yan J; Jin Z; Chen S; Wang Y; Zhang LW; Wang Y
    J Nanobiotechnology; 2022 Aug; 20(1):372. PubMed ID: 35953828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer.
    Won JE; Wi TI; Lee CM; Lee JH; Kang TH; Lee JW; Shin BC; Lee Y; Park YM; Han HD
    Acta Biomater; 2021 Dec; 136():508-518. PubMed ID: 34626819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.